Associate Professor, Surgery, University of Virginia School of Medicine
General Surgery
Dr. Daniel G. Maluf, MD
|
|
Give Review
Daniel Maluf is an expert in the field of General Surgery. He researched medicine at University of Virginia School of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification". Doctor Daniel G. Maluf, MD is a published MD. He has 76 papers published. The most current publication "Hidden Inflammatory Molecular Signatures in Graft Kidney Biopsies: Silent markers of graft fate?" Doctor Daniel G. Maluf, MD is registered with Medicare.
Publications
- The High-Risk Age Window After Pediatric Liver Transplantation: Modeling Allograft Loss Using Mathematical Tools.
- Hidden Inflammatory Molecular Signatures in Graft Kidney Biopsies: Silent markers of graft fate?
- Evaluation of Molecular Profiles in Calcineurin Inhibitor Toxicity Post-Kidney Transplant: Input to Chronic Allograft Dysfunction.
- Liver transplant complications in hepatitis C infected recipients: recurrence versus rejection.
- Photodynamic Therapy Provides Local Control of Cholangiocarcinoma in Patients Awaiting Liver Transplantation.
- Optimizing Recovery, Utilization and Transplantation Outcomes for Kidneys From Small, ≤20 kg, Pediatric Donors.
- The urine microRNA profile may help monitor post-transplant renal graft function.
- Regulation of Molecular Pathways in Ischemia-Reperfusion Injury After Liver Transplantation.
- Hepatic disease biomarkers and liver transplantation: what is the potential utility of microRNAs?
- MicroRNA Signature at the Time of Clinical HCV Recurrence Associates With Aggressive Fibrosis Progression Post-Liver Transplantation.
- MiRNAs in kidney transplantation: potential role as new biomarkers.
- MicroRNAs as Biomarkers in Solid Organ Transplantation.
- Molecular profiles of HCV cirrhotic tissues derived in a panel of markers with clinical utility for hepatocellular carcinoma surveillance.
- Biomarkers of disease differentiation: HCV recurrence versus acute cellular rejection.
- Reduced expression of inflammatory genes in deceased donor kidneys undergoing pulsatile pump preservation.
- En bloc kidney transplantation from pediatric donors: comparable outcomes with living donor kidney transplantation.
- Pretransplant transcriptome profiles identify among kidneys with delayed graft function those with poorer quality and outcome.
- Gene expression changes are associated with loss of kidney graft function and interstitial fibrosis and tubular atrophy: diagnosis versus prediction.
- Distinctive gene expression profiles characterize donor biopsies from HCV-positive kidney donors.
- Identifying genes for establishing a multigenic test for hepatocellular carcinoma surveillance in hepatitis C virus-positive cirrhotic patients.
- Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
- Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma.
- Incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomes.
- Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation.
- Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis.
- Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome.
- Angiogenesis soluble factors as hepatocellular carcinoma noninvasive markers for monitoring hepatitis C virus cirrhotic patients awaiting liver transplantation.
- Living kidney donors requiring transplantation: focus on African Americans.
- Is hepatic transplantation justified for primary liver cancer?
- Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function.
- Hepatitis C virus infection and kidney transplantation: predictors of patient and graft survival.
- Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results.
- Utilization of extended donor criteria liver allograft: Is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient?
- Molecular techniques for identifying HCC origin and biology after orthotopic liver transplantation.
- Differentially expressed genes between early and advanced hepatocellular carcinoma (HCC) as a potential tool for selecting liver transplant recipients.
- Study of mRNA growth factors in urinary cells of kidney transplant recipients as predictors of chronic allograft nephropathy.
- Apolipoprotein E genotypes as predictors of high-risk groups for developing hyperlipidemia in kidney transplant recipients undergoing sirolimus treatment.
- Reasons for non-use of recovered kidneys: the effect of donor glomerulosclerosis and creatinine clearance on graft survival.
- Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
- Engraftment measurement in human liver tissue after liver cell transplantation by short tandem repeats analysis.
- Hepatic artery thrombosis after liver transplantation and genetic factors: prothrombin G20210A polymorphism.
- Hardikar syndrome: a case requiring liver transplantation.
- Identifying biomarkers as diagnostic tools in kidney transplantation.
- Living donor liver transplantation for neonatal hemochromatosis using non-anatomically resected segments II and III: a case report.
- Identifying genes progressively silenced in preneoplastic and neoplastic liver tissues.
- Hepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression.
- Molecular pathways involved in loss of graft function in kidney transplant recipients.
- High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma.
- Adult living donor versus deceased donor liver transplantation: a 10-year prospective single center experience.
- Proteomics and liver fibrosis: identifying markers of fibrogenesis.
- Effect of hyponatraemia on outcomes following orthotopic liver transplantation.
- Salvage procedure for unexpected portal vein thrombosis in living donor liver transplantation.
- Hepatic angiosarcoma and liver transplantation: case report and literature review.
- Adult living donor versus deceased donor liver transplantation: a 6-year single center experience.
- Molecular and clinical response to angiotensin II receptor antagonist in kidney transplant patients with chronic allograft nephropathy.
- Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list.
- Massive hepatic artery atherosclerosis of an otherwise suitable donor liver: a case report.
- Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC): safety and efficacy.
- Hepatocellular carcinoma: strategy for optimizing surgical resection, transplantation and palliation.
- Immunobiology and long-term graft function in a transplant heterotopic renal rat model.
- Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
- Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.
- Polymorphisms in cytokines and growth factor genes and their association with acute rejection and recurrence of hepatitis C virus disease in liver transplantation.
- Molecular markers in stored kidneys using perfluorocarbon-based preservation solution: preliminary results.
- Establishing the molecular pathways involved in chronic allograft nephropathy for testing new noninvasive diagnostic markers.
- Multimodality therapy and liver transplantation in patients with cirrhosis and hepatocellular carcinoma: 6 years, single-center experience.
- A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
- Gene expression patterns in deceased donor kidneys developing delayed graft function after kidney transplantation.
- Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 years.
- MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA.
- Molecular classification and clonal differentiation of hepatocellular carcinoma: the step forward for patient selection for liver transplantation.
- Transcriptome at the time of hepatitis C virus recurrence may predict the severity of fibrosis progression after liver transplantation.
- Molecular pathways differentiate hepatitis C virus (HCV) recurrence from acute cellular rejection in HCV liver recipients.
- Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis.
- Kidney grafts from HCV-positive donors: advantages and disadvantages.
Schools
Universidad Nacional De Cordoba
Med
Virginia Commonwealth University
Procedures Preformed
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Gallbladder Removal (Cholecystectomy), Laparoscopic
- Hepatectomy
- Inguinal Hernia Repair, Open
- View All
Doctors Specialties
- General Surgery
- Transplant Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Virginia School of Medicine
Hospital
-
University of Virginia Medical Center
Drug Facts
| NPI NUMBER | 1447336102 | |
| NPPES Provider LastName | MALUF | |
| NPPES Provider FirstName | DANIEL | |
| NPPES Provider ZIPCode | 229080001 | |
| NPPES Provider State | VA | |
| Specialty Description | General Surgery | |
| Total Claim Count | 213.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1447336102 |
| Last Name Of The Provider | MALUF |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
Dr. Victoria L. Vastine, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. David Brenin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Charles M. Friel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Victor M. Zaydfudim, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Shayna L. Showalter, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bartholomew J. Kane, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ivan K. Crosby, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Michael D. Trahan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicholas L. Bandy, MD |
|
|
Dr. Daniel Gilsdorf, MD |
|
|
Dr. Christopher A. Guidry, MD |
|
|
Dr. Matthew L. Stone, MD |
|
|
Dr. Benjamin A. Hirsch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Troy L. Shell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Daniel Murariu
This Doctor is OpenDoctor Recommended.
|